Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1281-1290 of 1,460) with videos related to

Pageof 146
Sort By:
Vaccines|January 26, 2021
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing ResponsesYongping Yang, Wei Shi, Olubukola M Abiona, et al.
JAMA|February 15, 2001
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Nature Communications|December 22, 2016
A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuationChristopher C Stobart, Christina A Rostad, Zunlong Ke, et al.
Immunity|July 28, 2019
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza HemagglutininSarah F Andrews, Michael J Chambers, Chaim A Schramm, et al.
The Journal of Infectious Diseases|November 5, 2019
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K Cunningham, Elizabeth J McFarland, R Leavitt Morrison, et al.
The Journal of Infectious Diseases|January 19, 2010
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)Hannah Kibuuka, Robert Kimutai, Leonard Maboko, et al.
Immunity|November 15, 2023
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidaseRuipeng Lei, Wooseob Kim, Huibin Lv, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2014
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremiaShari N Gordon, Melvin N Doster, Rhonda C Kines, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccinesSandhya Bangaru, Abigail M Jackson, Jeffrey Copps, et al.
Pageof 146

Showing results (1281-1290 of 1,460) with videos related to

Sort By:
Pageof 146
Vaccines|January 26, 2021
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing ResponsesYongping Yang, Wei Shi, Olubukola M Abiona, et al.
JAMA|February 15, 2001
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Nature Communications|December 22, 2016
A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuationChristopher C Stobart, Christina A Rostad, Zunlong Ke, et al.
Immunity|July 28, 2019
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza HemagglutininSarah F Andrews, Michael J Chambers, Chaim A Schramm, et al.
The Journal of Infectious Diseases|November 5, 2019
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K Cunningham, Elizabeth J McFarland, R Leavitt Morrison, et al.
The Journal of Infectious Diseases|January 19, 2010
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)Hannah Kibuuka, Robert Kimutai, Leonard Maboko, et al.
Immunity|November 15, 2023
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidaseRuipeng Lei, Wooseob Kim, Huibin Lv, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2014
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremiaShari N Gordon, Melvin N Doster, Rhonda C Kines, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccinesSandhya Bangaru, Abigail M Jackson, Jeffrey Copps, et al.
Pageof 146